Bhavsar Amit, Aris Emmanuel, Harrington Lauriane, Simeone Jason C, Ramond Anna, Lambrelli Dimitra, Papi Alberto, Boulet Louis-Philippe, Meszaros Kinga, Jamet Nicolas, Sergerie Yan, Mukherjee Piyali
Europe Medical Affairs, GSK, Wavre, Belgium.
Real-World Analytics, GSK, Wavre, Belgium.
J Asthma Allergy. 2022 Jan 11;15:35-51. doi: 10.2147/JAA.S335960. eCollection 2022.
The impact of pertussis in individuals with asthma is not fully understood. We estimated the incidence, health care resource utilization (HCRU), and direct medical costs (DMC) of pertussis in patients with asthma.
In this retrospective cohort study, the incidence rate of pertussis (identified using diagnostic codes) among individuals aged ≥50 years with an asthma diagnosis was assessed during 2009-2018 using Clinical Practice Research Datalink and Hospital Episode Statistics databases. HCRU and DMC were compared - between patients with diagnoses of asthma and pertussis (asthma+/pertussis+) and propensity score-matched patients with a diagnosis of asthma without pertussis (asthma+/pertussis-) - in the months around the pertussis diagnosis (-6 to +11).
Among 687,105 individuals, 346 had a reported pertussis event (incidence rate: 9.6/100,000 person-years of follow-up; 95% confidence interval: 8.6-10.7). HCRU and DMC were assessed among 314 asthma+/pertussis+ patients and 1256 matched asthma+/pertussis- controls. Baseline HCRU was similar in both cohorts, but increases were observed in the asthma+/pertussis+ cohort from -6 to -1 month before to 2-5 months after diagnosis. Rates of accident and emergency visits, general practitioner (GP)/nurse visits, and GP prescriptions were 4.3-, 3.1-, and 1.3-fold, respectively, in the asthma+/pertussis+ vs asthma+/pertussis- cohorts during the month before diagnosis; GP/nurse visit rates were 2.0- and 1.2-fold during 0-2 and 2-5 months after diagnosis, respectively (all <0.001). DMC was 1.9- and 1.6-fold during the month before and 2 months from diagnosis, respectively, in the asthma+/pertussis+ vs asthma+/pertussis- cohorts (both <0.001). During months -1 to +11, DMC in the asthma+/pertussis+ cohort was £370 higher than in the asthma+/pertussis- controls.
A pertussis diagnosis among adults aged ≥50 years with asthma resulted in significant increases in HCRU and DMC across several months around diagnosis, suggesting lengthy diagnosis times and highlighting the need for prevention strategies.
百日咳对哮喘患者的影响尚未完全明确。我们估算了哮喘患者中百日咳的发病率、医疗资源利用情况(HCRU)及直接医疗费用(DMC)。
在这项回顾性队列研究中,利用临床实践研究数据链和医院病历统计数据库,评估了2009年至2018年期间年龄≥50岁且诊断为哮喘的个体中百日咳的发病率(通过诊断编码确定)。比较了百日咳诊断前后数月(-6至+11)内诊断为哮喘并患有百日咳的患者(哮喘+/百日咳+)与倾向得分匹配的未患百日咳的哮喘诊断患者(哮喘+/百日咳-)的HCRU和DMC。
在687,105名个体中,有346人报告发生了百日咳事件(发病率:9.6/100,000人年随访;95%置信区间:8.6 - 10.7)。对314名哮喘+/百日咳+患者和1256名匹配的哮喘+/百日咳-对照者进行了HCRU和DMC评估。两个队列的基线HCRU相似,但哮喘+/百日咳+队列在诊断前-6个月至-1个月以及诊断后2至5个月出现了增加。在诊断前一个月,哮喘+/百日咳+队列与哮喘+/百日咳-队列相比,急诊就诊率、全科医生(GP)/护士就诊率和GP处方率分别为4.3倍、3.1倍和1.3倍;在诊断后0至2个月和2至5个月,GP/护士就诊率分别为2.0倍和1.2倍(均<0.001)。在诊断前一个月和诊断后2个月,哮喘+/百日咳+队列与哮喘+/百日咳-队列相比,DMC分别为1.9倍和1.6倍(均<0.001)。在-1至+11个月期间,哮喘+/百日咳+队列的DMC比哮喘+/百日咳-对照者高370英镑。
年龄≥50岁的哮喘成人患者被诊断为百日咳后,在诊断前后数月内HCRU和DMC显著增加,这表明诊断时间较长,并凸显了预防策略的必要性。